Epstein Forwarded Elite Health Care Investor List to His Inbox

In September 2013, an email chain surfaced involving biotech investor Boris Nikolic and Jeffrey Epstein, shedding light on Epstein’s connections to elite global health, finance, and pharmaceutical networks.

Email Chain Overview

The correspondence began with Andrew Farnum forwarding details to Boris Nikolic on September 15, 2013, asking if Nikolic was “leading this” in reference to a panel event scheduled for September 13, 2013, likely associated with JPMorgan.

Event Details

The panel was anticipated to attract approximately 250 attendees, including high-net-worth individuals (HNWIs), foundations, pharmaceutical companies, and other guests.

Following the main panel discussion, a private 20-minute meeting was planned exclusively with key investors from the Global Health Investment Fund (GHIF) to express gratitude for their partnerships.Key Meeting AttendeesThe email listed prominent participants expected at this private session, including:

• Jamie Dimon, CEO of JPMorgan Chase
• Jamie Cooper-Hohn, Founder and Non-Executive Chair of the Children’s Investment Fund Foundation (CIFF)
• Christian Paradis, Minister of International Development, Canada
• Charlotte Petri Gornitzka, Director General, Swedish International Development Cooperation Agency
• Ursula Mueller, Director General, BMZ (Germany)
• Klaus Mueller, Director, KfW
• Moncef Slaoui, Chairman Global R&D, GlaxoSmithKline
• Bob McMahon, Senior Vice President Government Relations, Public Policy and Corporate Responsibility, Merck
• Caroline Roan, President, Pfizer Foundation
• Sabina Cosic, Chief Investment Officer, Life Sciences, IFC

Forward to Epstein

On September 16, 2013, Boris Nikolic forwarded the entire thread to Jeffrey Epstein (using the email jeevacation@gmail.com).

He attached a related document titled “Event_JPM Panel 9-13-2013.docx” and explicitly noted: “Not for sending out. = Just for your info.”

Context and Significance

This exchange, drawn from documents in the U.S. Department of Justice’s recently released Epstein files (under the Epstein Files Transparency Act), underscores Epstein’s ongoing interest in—and apparent access to—high-level intersections of philanthropy, international development, and the pharmaceutical industry during that time.

Is This Real?

Yes, this Epstein file is authentic and comes from the recently released U.S. Department of Justice Epstein files (part of the large 2026 document dumps under the Epstein Files Transparency Act).

Similar emails and details involving Boris Nikolic, Epstein, JPMorgan connections (including Jamie Dimon), and global health/investment panels or funds from that period have surfaced in reporting on the Epstein documents. While the exact screenshot format may be from social media shares or leaks, the content aligns with verified releases showing Epstein’s ties to figures like Nikolic and broader elite networks in finance, philanthropy, and pharma. No major outlets have debunked this specific chain as fake.